Sigyn Therapeutics Inc (SIGY)
5.25
0.00 (0.00%)
USD |
OTCM |
Jun 14, 16:00
Sigyn Therapeutics 1 Year Total Returns (Daily): 87.50% for June 14, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 14, 2024 | 87.50% |
| June 13, 2024 | 54.41% |
| June 12, 2024 | 54.41% |
| June 11, 2024 | 54.41% |
| June 10, 2024 | 54.41% |
| June 07, 2024 | 44.23% |
| June 06, 2024 | 44.23% |
| June 05, 2024 | 87.50% |
| June 04, 2024 | 87.50% |
| June 03, 2024 | 87.50% |
| May 31, 2024 | 31.25% |
| May 30, 2024 | 15.14% |
| May 29, 2024 | 15.14% |
| May 28, 2024 | 15.14% |
| May 24, 2024 | 15.14% |
| May 23, 2024 | 15.14% |
| May 22, 2024 | 15.14% |
| May 21, 2024 | 15.14% |
| May 20, 2024 | 15.14% |
| May 17, 2024 | 15.14% |
| May 16, 2024 | 15.14% |
| May 15, 2024 | 18.24% |
| May 14, 2024 | -17.13% |
| May 13, 2024 | -17.13% |
| May 10, 2024 | -17.13% |
| Date | Value |
|---|---|
| May 09, 2024 | -17.13% |
| May 08, 2024 | -17.13% |
| May 07, 2024 | -17.13% |
| May 06, 2024 | -12.99% |
| May 03, 2024 | -12.99% |
| May 02, 2024 | -12.99% |
| May 01, 2024 | -8.84% |
| April 30, 2024 | 16.50% |
| April 29, 2024 | 23.11% |
| April 26, 2024 | 23.11% |
| April 25, 2024 | 11.65% |
| April 24, 2024 | 11.65% |
| April 23, 2024 | 11.65% |
| April 22, 2024 | 11.65% |
| April 19, 2024 | 11.65% |
| April 18, 2024 | 6.80% |
| April 17, 2024 | 18.45% |
| April 16, 2024 | 18.45% |
| April 15, 2024 | 18.45% |
| April 12, 2024 | 16.50% |
| April 11, 2024 | 6.80% |
| April 10, 2024 | 6.80% |
| April 09, 2024 | 6.80% |
| April 08, 2024 | 6.80% |
| April 05, 2024 | 6.80% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-93.89%
Minimum
Aug 24 2020
790.9%
Maximum
Aug 19 2021
-18.71%
Average
-46.25%
Median
Jan 03 2024
1 Year Total Returns (Daily) Benchmarks
| CEL-SCI Corp | -46.28% |
| AIM ImmunoTech Inc | -1.73% |
| IGC Pharma Inc | 39.13% |
| NovaBay Pharmaceuticals Inc | -89.69% |
| Protalix BioTherapeutics Inc | -50.22% |